BriefCase-Triage vs AVIEW

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Aidoc
VS
by Coreline Soft Co.

AI Verdict

Aidoc's BriefCase-Triage is primarily focused on rapidly detecting and prioritizing a broad range of critical findings across various medical images for acute care, aiming to reduce time-to-treatment. In contrast, Coreline Soft's AVIEW specializes in comprehensive AI solutions for the early detection, diagnosis, and monitoring of specific lung conditions like lung cancer, COPD, and coronary artery calcification from CT scans. While both enhance radiology workflows with AI and have FDA clearance, their core applications and target pathologies differ significantly, making them adjacent rather than direct competitors.

Choose BriefCase-Triage if…

Choose BriefCase-Triage if your health system requires a broad, real-time AI solution to rapidly detect and prioritize critical findings across a wide range of medical imaging studies. This tool excels at streamlining emergency workflows by ensuring urgent cases are immediately flagged for physician review, significantly reducing response times and improving overall patient outcomes in high-volume environments.

View BriefCase-Triage →

Choose AVIEW if…

Choose AVIEW if your institution needs specialized, in-depth AI analysis for the comprehensive detection, diagnosis, and monitoring of specific thoracic conditions, such as lung cancer, COPD, and coronary artery calcification. This platform is ideal for detailed quantification, 3D visualizations, and long-term follow-up of these conditions, supporting precise clinical decision-making and disease management programs.

View AVIEW →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature BriefCase-Triage AVIEW
Pricing Enterprise pricing starts at approximately $50,000 per site per year. Subscription; one-off payment
Deployment Cloud-based. Aidoc's platform runs on AWS and Azure. The deployment process is described as lightweight, straightforward, and can be up and running in 2 to 3 weeks with minimal effort from facility IT. Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated
EHR Integration Epic Not specified

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BriefCase-Triage

BriefCase-Triage offers seamless integration with existing hospital systems and a robust mobile app for care coordination, including integrated EHR data and secure chat, which enhances immediate, actionable usability for multidisciplinary teams. While AVIEW also offers optimized UI/UX and mobile access, Aidoc's emphasis on real-time notifications and comprehensive mobile functionality for triage workflows provides a slight advantage.

Clinical Value

AVIEW

AVIEW demonstrates exceptional clinical value through its specialized, quantitative diagnostic and monitoring capabilities for lung and cardiac conditions, backed by numerous published studies. Its performance as a 'first reader' in lung cancer screening, significantly reducing false negatives and radiologist workload, showcases a profound impact on diagnostic precision and efficiency.

Pricing & Value

AVIEW

AVIEW offers more transparent pricing models, including one-off payments and subscriptions based on installations, users, or analyses, and is expanding to a usage-based SaaS model for emergency rooms. While BriefCase-Triage offers flexible payment options and claims a high ROI, AVIEW's clearer pricing structure provides more predictability for budgeting.

Enterprise Readiness

BriefCase-Triage

BriefCase-Triage demonstrates superior enterprise readiness with a significantly larger global customer base of over 1,600 hospitals and a more comprehensive list of explicit compliance certifications including SOC2, GDPR, MDSAP, ISO 13485, and MDR. Its aiOSu2122 platform is specifically designed for scalable, multi-condition AI deployment within complex health systems, having analyzed over 100 million patient cases.

Innovation

BriefCase-Triage

BriefCase-Triage demonstrates a broader innovation strategy by leveraging Aidoc's self-developed AI foundation model, CAREu2122, to provide a comprehensive triage solution across multiple indications with an 'order-of-magnitude reduction in false alerts.' Its roadmap includes expanding to all CT and X-ray workflows and developing automated draft report creation, indicating a more foundational and expansive approach to AI in healthcare.

Support & Docs

BriefCase-Triage

Aidoc's BriefCase-Triage is supported by a comprehensive Customer Success team that provides training, educational content, and ongoing support, alongside an extensive 'AI Learning Center' offering a wide array of resources including clinical studies, FAQs, and product information. Coreline Soft offers customer service contacts and demonstrations, but lacks the detailed, proactive support and documentation framework provided by Aidoc.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature BriefCase-Triage AVIEW
Name BriefCase-Triage AVIEW
Company Aidoc Medical Coreline Soft Co.
Description FDA-cleared AI solution for physicians, enhancing radiology workflows by rapidly detecting and prioritizing critical findings in medical images. AI platform offers comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows.
Key Features AI-powered analysis of medical imaging, Real-time alerts and notifications, Seamless integration with existing hospital systems (PACS, EHR), Prioritization of critical cases, Order-of-magnitude reduction in false alerts, Comprehensive triage solution (multiple indications in one workflow), Mobile app for care coordination, Continuous learning model AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score), Emphysema quantification and low attenuation area (LAA) analysis, Coronary artery calcium (CAC) scoring (Agatston, volume, mass score, risk stratification), Automated segmentation of lung lobes, airways, vessels, and coronary arteries, 3D visualizations and comprehensive PDF reports, Workflow automation and integration with PACS/RIS/CIS, Follow-up registration and nodule matching for serial CT scans, Interstitial Lung Disease (ILD) pattern analysis (AVIEW Lung Texture)

Videos

Demos, reviews, and walkthroughs featuring BriefCase-Triage and AVIEW.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

BriefCase-Triage by Aidoc is an AI solution for rapidly detecting and prioritizing critical findings in medical images across multiple indications, supporting specialties like Cardiology, Emergency Medicine, General Surgery, Neurology, Oncology, and Radiology. AVIEW by Coreline Soft focuses on comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, primarily serving Cardiology, Pulmonology, and Radiology.
BriefCase-Triage emphasizes AI-powered analysis for real-time alerts, prioritization of critical cases, and an order-of-magnitude reduction in false alerts across comprehensive triage solutions. AVIEW provides detailed features such as AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score), emphysema quantification, and coronary artery calcium scoring with 3D visualizations and comprehensive PDF reports.
Yes, BriefCase-Triage includes a mobile app for care coordination. The provided information for AVIEW does not explicitly mention a mobile app for its medical imaging diagnostic platform, though other products named 'AView' exist with mobile apps for different purposes.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.